Barclays logo

Institution

Barclays Financial Research Hub

Barclays research maintains a multi-faceted approach, balancing specific equity selections with broader thematic shifts across global markets. Analysts are currently emphasizing a rotation toward Value within European equities, citing that Momentum is losing steam and Quality lacks fundamental support amid hawkish ECB policy. Stock-specific conviction remains high in pockets of the biotech sector, notably with an Overweight rating on C4 Therapeutics, while the firm remains cautious on Apple's near-term AI integration due to monetization uncertainties. Beyond corporate analysis, the research underscores significant macroeconomic trends, including the impact of JPY weakness driven by shifting Japanese household asset allocations and retail FX positioning. These reports collectively highlight a focus on execution risks, sector-specific consolidation, and the navigation of inflationary headwinds through disciplined, factor-based investment strategies.

115 reports available

All reports

Page 4 of 5

About Barclays

Visit Website

Related

EquitiesMacro Economic IndicatorsRates CreditHealth CareFinancials

Get full access

14-day trial · card required